Fund Holdings — Artia Global Partners LP

Total Portfolio Value
$247.96M
Total Bought
$115.43M
Total Sold
$219.86M
Net Transaction
-$104.44M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ARCELLX INC
COMMON STOCK
0229,785+229,785017,6227.11%+17,622
MERUS N V80,171463,840+383,6694,00519,5047.87%+15,499
NUVALENT INC15,437204,045+188,6081,57915,9736.44%+14,393
JANUX THERAPEUTICS INC(JANX)0162,976+162,97608,7263.52%+8,726
SOLENO THERAPEUTICS INC274,424494,424+220,00013,85622,2248.96%+8,369
REVOLUTION MEDICINES INC(RVMD)95,885284,190+188,3054,34812,4305.01%+8,082
INSMED INC(INSM)52,939167,939+115,0003,86511,5954.68%+7,730
VERONA PHARMA PLC148,590255,318+106,7284,27511,8574.78%+7,582
PROTAGONIST THERAPEUTICS INC124,440293,851+169,4115,60011,3434.57%+5,743
VAXCYTE INC(PCVX)76,255162,255+86,0008,71413,2825.36%+4,569
ALNYLAM PHARMACEUTICALS INC(ALNY)35,00056,400+21,4009,62613,2715.35%+3,645
RHYTHM PHARMACEUTICALS INC(RYTM)050,000+50,00002,7991.13%+2,799
INTRA-CELLULAR THERAPIES INC216,519219,719+3,20015,84318,3517.40%+2,508
ENLIVEN THERAPEUTICS INC0102,900+102,90002,3150.93%+2,315
VIRIDIAN THERAPEUTICS INC(VRDN)0100,000+100,00001,9170.77%+1,917
TG THERAPEUTICS INC(TGTX)054,515+54,51501,6410.66%+1,641
TARSUS PHARMACEUTICALS INC(TARS)020,811+20,81101,1520.46%+1,152
NEUROCRINE BIOSCIENCES INC(NBIX)45,00045,00005,1856,1432.48%+958
TECTONIC THERAPEUTIC INC(TECX)016,650+16,65007690.31%+769
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
54,28554,28509011,3950.56%+494
EYEPOINT PHARMACEUTICALS INC(EYPT)156,300216,700+60,4001,2491,6140.65%+366
SPRINGWORKS THERAPEUTICS INC53,93053,93001,7281,9480.79%+221
CENTESSA PHARMACEUTICALS PLC80,38080,38001,2851,3460.54%+61
CRINETICS PHARMACEUTICALS IN(CRNX)45,76545,76502,3392,3400.94%+1
XENON PHARMACEUTICALS INC(XENE)40,00040,00001,5751,5680.63%-7
CHARLES RIV LABS INTL INC(CRL)6,3056,30501,2421,1640.47%-78
ASCENDIS PHARMA A/S(ASND)7,4407,44001,1111,0240.41%-87
ANNEXON INC(ANNX)172,226172,22601,0208840.36%-136
Q32 BIO INC(FIXX)4,7050-4,7052100—-210
MEREO BIOPHARMA GROUP PLC(MREO)421,359421,35901,7321,4750.59%-257
SUMMIT THERAPEUTICS INC(SMMT)14,5120-14,5123180—-318
MADRIGAL PHARMACEUTICALS INC(MDGL)1,5570-1,5573300—-330
ACELYRIN INC93,1140-93,1144590—-459
LARIMAR THERAPEUTICS INC(LRMR)90,4900-90,4905930—-593
DISC MEDICINE INC(IRON)13,4400-13,4406600—-660
ALECTOR INC193,3170-193,3179010—-901
SYNDAX PHARMACEUTICALS INC(SNDX)48,2630-48,2639290—-929
SILENCE THERAPEUTICS PLC(SLN)52,4760-52,4769540—-954
CORBUS PHARMACEUTICALS HLDGS(CRBP)47,4000-47,4009780—-978
KURA ONCOLOGY INC(KURA)57,1780-57,1781,1170—-1,117
KEROS THERAPEUTICS INC(KROS)20,0000-20,0001,1610—-1,161
IONIS PHARMACEUTICALS INC(IONS)30,4790-30,4791,2210—-1,221
ARGENX SE(ARGX)15,13811,311-3,8278,2066,9562.81%-1,250
IDEAYA BIOSCIENCES INC(IDYA)62,9920-62,9921,9960—-1,996
ASTRAZENECA PLC(AZN)190,752190,752014,86112,4985.04%-2,363
CELLDEX THERAPEUTICS INC NEW(CLDX)75,3000-75,3002,5590—-2,559
DYNE THERAPEUTICS INC(DYN)119,4880-119,4884,2920—-4,292
AXSOME THERAPEUTICS INC(AXSM)87,8480-87,8487,8950—-7,895
VERTEX PHARMACEUTICALS INC(VRTX)18,9000-18,9008,7900—-8,790
VIKING THERAPEUTICS INC(VKTX)532,87990,279-442,60033,7373,6331.47%-30,104
NOVO-NORDISK A S(NVO)741,743200,000-541,74388,31917,2046.94%-71,115
ELI LILLY & CO(LLY)92,5930-92,59382,0320—-82,032
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q4 2024 | TickerTrail